Trending News

Trump Administration Issues AI Action Plan and AI Executive Orders

Winning the Race: America’s AI Action Plan

Innovation Over Regulation – Trump Unveils America’s AI Action Plan

Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

Labor Secretary Lifts Abeyance on OFCCP Disability and Veteran Matters

In Case You Missed It: DOL Prohibited From Collecting Liquidated Damages in Wage & Hour Pre-Litigation Investigations

SEC’s New Concept Release on Foreign Private Issuer Standards

What Regulated Businesses Should Know About the Supreme Court’s Recent NEPA Decision

NEW ATDS BATTLEGROUND: Texas Passes HUGE NEW AMENDMENT to Its State Telemarketing Law Reviving The Risk of Autodialer Cases

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

OBI Pharma Announces U.S. FDA Clearance of IND Application for a Phase 1/2 Study of OBI-902, a Trop-2 Targeting ADC
Posted On Wednesday, April 30, 2025
Nxera Pharma’s Partner Neurocrine Biosciences Initiates Phase 3 Registrational Program of NBI-1117568 as a Potential Treatment for Adults with Schizophrenia
Posted On Wednesday, April 30, 2025
Dimerix and Amicus Therapeutics Announce Exclusive License Agreement for DMX-200 in the United States
Posted On Wednesday, April 30, 2025
Nxera Pharma Appoints Top-Ranked Biopharma Investment Analyst Shinya Tsuzuki as Head of Investor Relations
Posted On Wednesday, April 30, 2025
Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq
Posted On Wednesday, April 30, 2025
Revolution Medicines to Report Financial Results for First Quarter 2025 After Market Close on May 7, 2025
Posted On Wednesday, April 30, 2025
Codexis to Report First Quarter 2025 Financial Results on May 14
Posted On Wednesday, April 30, 2025
Vaxart to Present at the Citizens Life Sciences Conference
Posted On Wednesday, April 30, 2025
Scorpius Holdings Provides 2024 Year-End Business Update; Implements Strategic Cost Reductions and Operational Streamlining
Posted On Wednesday, April 30, 2025
Bolt Biotherapeutics Presents Preclinical Results for Next-Generation Boltbody™ ISACs targeting CEA and PD-L1 at AACR Annual Meeting 2025
Posted On Wednesday, April 30, 2025
Terns Pharmaceuticals to Participate in The Citizens Life Sciences Conference
Posted On Wednesday, April 30, 2025
Cytokinetics to Participate in May Investor Conferences
Posted On Wednesday, April 30, 2025
Burn clinicians present positive findings of the DeepView® System’s accuracy at the American Burn Association annual meeting
Posted On Wednesday, April 30, 2025
CD8 Technology Signs Letter of Intent for Tevogen Bio’s In-House Manufacturing Facility, Marking First Phase of Up to $50 Million Commitment
Posted On Wednesday, April 30, 2025
Scilex Holding Company Regains Compliance with NASDAQ Minimum Bid Price Rule
Posted On Wednesday, April 30, 2025
Cosmos Health CEO Greg Siokas Acquires 1,466,764 Shares Valued at $526,000 Over the Past Week; 2,777,469 Shares Acquired Over the Past Five Months for $1,325,000
Posted On Wednesday, April 30, 2025
Best Probiotics for Bloating and Gas 2025: Top Probiotic Gut Health Supplements from YourBiology
Posted On Wednesday, April 30, 2025
NeuroSigma Announces New Clinical Trial of Monarch eTNS System for Treatment of ADHD in Children with Fetal Alcohol Syndrome at UCLA
Posted On Wednesday, April 30, 2025
Arialief Reviews (DOCTOR INVESTIGATION REVEALS) Natural, Science-Backed Relief for Chronic Pain & Inflammation
Posted On Wednesday, April 30, 2025
X-Chem Expands Strategic Collaboration With Orion Pharma to Accelerate Orion’s Early Drug Discovery From Hit to Candidate
Posted On Wednesday, April 30, 2025
BioSyent to Present at 2025 Bloom Burton & Co. Healthcare Investor Conference
Posted On Wednesday, April 30, 2025
Medicenna Presents Promising Preclinical Data from its First-in-Class Tumor Targeted and Conditionally Activated Anti-PD-1-IL-2 Bifunctional Superkine at the Annual 2025 AACR Meeting
Posted On Wednesday, April 30, 2025
INVO Fertility Announces 2024 Financial Results with 116% Annual Revenue Growth and Further Improvements in Adjusted EBITDA
Posted On Wednesday, April 30, 2025
Senti Bio to Present at the Citizens JMP Life Sciences Conference
Posted On Wednesday, April 30, 2025
PathAI to Present at Digestive Disease Week
Posted On Wednesday, April 30, 2025

Print